Spinal morphine/clonidine antinociceptive synergism: Involvement of G proteins and N-type voltage-dependent calcium channels

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1392-1407

  Wei, Zhong You ^a   Karim, Farzana ^a   Roerig, Sandra C ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE SULFATE; NIFEDIPINE; OMEGA CONOTOXIN GVIA; PERTUSSIS TOXIN; VERAPAMIL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; DRUG RECEPTOR BINDING; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LATENT PERIOD; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPINAL CORD; TAIL FLICK TEST;

ANALGESICS, OPIOID; ANIMALS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS; CLONIDINE; DRUG SYNERGISM; GTP-BINDING PROTEINS; ION CHANNEL GATING; MALE; MEMBRANE POTENTIALS; MICE; MORPHINE; PAIN; PERTUSSIS TOXIN; RECEPTORS, ADRENERGIC, ALPHA-2; SIGNAL TRANSDUCTION; SPINAL CORD; VIRULENCE FACTORS, BORDETELLA;

EID: 0011871927     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (116)

1. ABE, T., KOYANO, K., SAISU, H., NISHIUCHI, Y. AND SAKAKIBARA, S.: Binding of ω-conotoxin to receptor sites associated with the voltage-sensitive calcium channel. Neurosci. Lett. 71: 203-208, 1986.
2. 2+] is reduced by clonidine and dynorphin A (1-13) and increased by idazoxan. Eur. J. Pharmacol. 142: 261-266, 1987.
3. ANTKIEWIEZ-MICHALUK, L., MICHALUK, J., ROMANSKA, I. AND VATULANI, J.: Reduction of morphine dependence and potentiation of analgesia by chronic coadministration of nifedipine. Psychopharmacy 111: 457-464, 1993.
4. AOSAKI, T. AND KASAI, H.: Characterization of two kinds of high-voltage-activated Ca-channel currents in chick sensory neurons. Pflugers Arch. 414: 150-156, 1989.
5. ATWEH, S. F. AND KUHAR, M. J.: Autoradiographic localization of opiate receptors in rat brain I: Spinal cord and lower medulla. Brain Res. 142: 53-67, 1977.
6. BASILICO, L., PAROLARO, D., RUBINO, T., GORI, E. AND GIAGNONI, G.: Influence of ω-conotoxin on morphine analgesia and withdrawal syndrome in rats. Eur. J. Pharmacol. 218: 75-81, 1992.
7. 2+ channels. Trends Pharmacol. Sci. 9: 257-261, 1988.
8. BELL, J. A.: Selective blockade of spinal reflexes by ω-conotoxin in the isolated spinal cord of the neonatal rat. Neuroscience 52: 711-716, 1993.
9. BENEDEK, G. AND SZIKSZAY, M.: Potentiation of thermoregulatory and analgesic effects of morphine by calcium antagonists. Pharmacol. Res. Commun. 16: 1009-1018, 1984.
10. BENHAMOU, D., NARCHI, P., HAMZA, J., MARX, M., PEYHOL, M. T. AND SEMBEIL, F.: Addition of oral clonidine to postoperative patient-controlled analgesia with i.v. morphine. Br. J. Anaesth. 72: 537-540, 1994.
11. BENOLIEL, J. J., BOURGOIN, S., MAUBORGNE, A., LEGRAND, J. C., HAMON, M. AND CESSELIN, F.: Differential inhibitory/stimulatory modulation of spinal CCK release by μ and δ opioid agonists, and selective blockade of μ-dependent inhibition by κ receptor stimulation. Neurosci. Lett. 124: 204-207, 1991.
12. BERGAMASCHI, S., GOVONI, S., BATTAINI, F., TRABUCCHI, M., MONACO, S. D. AND PARENTI, M.: G.: Protein modulation of ω-conotoxin binding sites in neuroblastoma x glioma NG108-15 hybrid cells. J. Neurochem. 59: 536-543, 1992.
13. BOURINET, E., SOONG, T. W., STEA, A. AND SNUTCH, T. P.: Determinants of the G.: protein-dependent opioid modulation of neuronal calcium channels. Proc. Natl. Acad. Sci. U.S.A. 93: 1486-1491, 1996.
14. BOURSON, A., MOSER, P. C., GOWER, A. J. AND MIR, A. K.: Central and peripheral effects of the dihydropyridine calcium channel activator Bay K 8644 in the rat. Eur. J. Pharmacol. 160: 339-347, 1989.
15. 2+ channels to release adenosine from spinal cord synaptosomes. J. Neurochem. 60: 894-901, 1993.
16. o with calcium channels by the calcium channel β-subunit in rat neurones. J. Physiol. 485.2: 365-372, 1995.
17. CHILDERS, S. R.: Opioid receptor-coupled second messenger systems. Life Sci. 48: 1991-2003, 1991.
18. CONTRERAS, E., TAMAYO, L. AND AMIGO, M.: Calcium channel antagonists increase morphine-induced analgesia and antagonize morphine tolerance. Eur. J. Pharmacol. 148: 463-466, 1988.
19. D'AMOUR, F. E. AND SMITH, D. L.: A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72: 74-79, 1941.
20. DEKOCK, M. F., PICHON, G. AND SCHOLTES, J.-L.: Intraoperative clonidine enhances postoperative morphine patient-controlled analgesia. Can. J. Anesth. 39: 537-544, 1992.
21. DELPOZO, E., CARO, G. AND BAEYENS, J. M.: Analgesic effects of several calcium channel blockers in mice. Eur. J. Pharmacol. 137: 155-160, 1987.
22. DEWEY, W. L., HARRIS, L. S., J. F. HOWES AND NUITE, J. A.: The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests, J. Pharmacol. Exp. Ther. 175: 435-442, 1970.
23. DIERSSEN, M., FLOREZ, J. AND HURLE, M. A.: Calcium channel modulation by dihydropyridines modifies sufentanil-induced antinociception in acute and tolerant conditions Naunyn-Schmiedeberg Arch. Pharmacol. 342, 559-565, 1990.
24. DIVERSE-PIERLUISSI, M., GOLDSMITH, P. K. AND DUNLAP, K.: Transmitter-mediated inhibition of N-type calcium channels in sensory neurons involves multiple GTP-binding proteins and subunits. Neuron 14: 191-200, 1995.
25. DOLPHIN, A. C.: Voltage-dependent calcium channels and their modulation by neurotransmitters and G proteins. Exp. Physiol. 80: 1-36, 1995.
26. DOLPHIN, A. C., PEARSON, H. A., MENON-JOHNSON, A. S., SWEENEY, M. I., SUTTON, K., HOUSTON, E., CULLEN, G. P. AND SCOTT, R. H.: Neurotransmitter release. Biochem. Soc. Trans. 21: 391-395, 1993.
27. DUNLAP, K. AND FISCHBACH, G. D.: Neurotransmitters decrease the calcium conductance activated by depolarization of embryonic chick sensory neurones. J. Physiol. 317: 519-535, 1981.
28. ERIKSSON, P. S., CARLSSON, B., ISAKSSON, O. G. P., HANSSON, E. AND RONNBACK, L.: Altered amounts of G-protein mRNA and cAMP accumulation after long-term opioid receptor stimulation of neurons in primary culture from the rat cerebral cortex. Mol. Brain Res. 14: 317-325, 1992.
29. FIELDING, S., WILKER, J., HYNES, M., SZEWCZAK, M., NOVICK, W. J. AND LAL, H.:A.:Comparison of clonidine with morphine for antinociceptive and anti-withdrawal actions. J. Pharmacol. Exp. Ther. 241: 361-365, 1978.
30. FISHBAIN, D. A., ROSOMOFF, H. L., CUTLER, R. AND ROSOMOFF, R. S.: Opiate detoxification protocols, a clinical manual. Ann. Clin. Psych. 5: 53-65, 1993.
31. FRANCKOWIAK, G., BECHEM, M., SCHRAMM, M. AND THOMAS, G.: The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels. Eur. J. Pharmacol. 114: 223-226,1985.
32. GHIGNONE, M., QUINTIN, L., DUKE, P. C., KEHLER, C. H. AND CALVILLO, O.: Effects of clonidine on narcotic requirements and hemodynamic response during induction of fentanyl anesthesia and endotracheal intubation. Anesthesiology 64: 36-42, 1986.
33. GOLD, M. S.: Opiate addiction and the locus coeruleus Psychiatry Clin. North Am. 16: 61-73, 1993.
34. GOLD, M. S., REDMOND, D. E. AND KLEBER, H. D.: Clonidine blocks acute opiate-withdrawal symptoms. Lancet 1: 929-930, 1978.
35. i3 complementary DNA. J. Biol. Chem. 263, 6476-6479, 1988.
36. GROSS, R. A. AND MACDONALD, R. L.: Dynorphin A selectively reduces a large transient (N-type) calcium current of mouse dorsal root ganglion neurons in cell culture. Proc. Natl. Acad. Sci. U.S.A. 84: 5469-5473. 1987.
37. HANO, K., KANETO, H. AND KAKUNAGA, T.: Significance of calcium ion in the morphine analgesia. Jpn. J. Pharmacol. 14: 227-229, 1964.
38. HARRIS, R. A., LOH, H. H. AND WAY, E. L.: Effects of divalent cations, cation chelators and an ionophore on morphine analgesia and tolerance J. Pharmacol. Exp. Ther. 195: 488-498, 1975.
39. o, regulates neuronal calcium channels. Nature 325: 445-447, 1987.
40. HESCHELER, J., ROSENTHAL, W., TRAUTWEIN, W. AND SCHULTZ, G.: Receptor-ion channel coupling through G proteins, pp. 383-409, In G Proteins, Academic Press, San Diego, CA, 1990.
41. HOEHN, K., REID, A. AND SAWYNOK, J.: Pertussis toxin inhibits antinociception produced by intrathecal injection of morphine, noradrenaline and baclofen Eur. J. Pharmacol. 146: 65-72, 1988.
42. HOFFMEISTER, F. AND TETTENBORN, D.: Calcium agonists and antagonists of the dihydropyridine type: Antinociceptive effects, interference with opiate-μ-receptor agonist and neuropharmacological actions in rodents. Psychopharmacy 90: 299-307, 1986.
43. HOLZ, G. G., RANE, S. G. AND DUNLAP, K.: GTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 319: 670-672, 1986.
44. HYLDEN, J. L. K. AND WILCOX, G. L.: Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci. 33: 789-795, 1983b.
45. HYLDEN, J. L. K. AND WILCOX, G. L.: Intrathecal morphine in mice: A new technique. Eur. J. Pharmacol. 67: 313-316, 1980.
46. HYLDEN, J. L. K. AND WILCOX, G. L.: Pharmacological characterization of substance P-induced nociception in mice: modulation by opioid and noradrenergic agonists at the spinal level. J. Pharmacol. Exp. Ther. 226: 398-404, 1983a.
47. KAKUNAGA, T., KANETO, H. AND HANO, K.: Pharmacologic studies on analgesics VII. Significance of the calcium ion in morphine analgesia, J. Pharmacol. Exp. Ther. 153: 134-141, 1966.
48. KENT, R. S., DELEAN, A. AND LEFKOWITZ, R. J.: A quantitative analysis of beta-adrenergic receptor interactions: Resolution of high and low affinity states of the receptor by computer modeling of ligand binding data. Mol. Pharmacol. 17: 14-23, 1980.
49. 2-adrenergic and opioid receptors in cultured bovine adrenal chromaffin cells. Pfugers Arch. 421: 131-137, 1992.
50. KURAISHI, Y., HIROTA, N., SATO, Y., KANEKO, S., SATOH, M. AND TAKAGI, H.: Noradrenergic inhibition of the release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res. 359: 177-182, 1985.
51. KUROSE, H., KATADA, T., AMANO, T. AND UI, M.: Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via α-adrenergic, cholinergic and opiate receptors in neuroblastoma x glioma hybrid cells. J. Biol. Chem. 258: 4870-4875, 1983.
52. LAW, P.-Y., LOUIE, A. K. AND LOH, H. H.: Effect of pertussis toxin treatment on the down-regulation of opiate receptors in neuroblastoma x glioma NG108-15 hybrid cells. J. Biol. Chem. 260: 14818-14823, 1985.
53. LAW, P. Y., HOM, D. S. AND LOH, H. H.: Opiate receptor down-regulation and desensitization in neuroblastoma x glioma NG108-15 hybrid cells are two separate cellular adaptation processes. Mol. Pharmacol. 24: 413-424, 1983.
54. LOWRY, O. H., ROSBROUGH, N. J., FARR, A. L. AND RANDALL, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 198: 265-275, 1951.
55. LUX, F., WELCH, S. P., BRASE, D. A. AND DEWEY, W. L.: Interaction of morphine with intrathecally administered calcium and calcium antagonists: Evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice. J. Pharmacol. Exp. Ther. 246: 500-507, 1988.
56. MALMBERG, A. B. AND YAKSH, T. L.: Effect of continuous intrathecal infusion of ω-conopeptides, N-type calcium-channel blockers, on behavior and antinociception in the formalin and hot-plate tests in rats, Pain, 60: 83-90, 1995.
57. MCCLESKEY, E. W., FOX, A. P., FELDMAN, D. H., CRUZ, L. J., OLIVERA, B. M., TSIEN, R. W. AND YOSHIKAMI, D.: ω-Conotoxin: Direct and persistent blockade of specific types of calcium channels in neurons but not muscle. Proc. Natl. Acad. Sci. U.S.A. 84: 4327-4331, 1987.
58. oa with the purified ω-conotoxin GVIA receptor. J. Biol. Chem. 269: 5-8, 1994.
59. i2. Biochem. J. 267: 391-398, 1990.
60. MILLER, R. J.: Multiple calcium channels and neuronal function. Science 235: 46-52, 1987.
61. 2+ channel blockers. Eur. J. Pharmacol. 217: 137-141, 1992.
62. MONASKY, M. S., ZINSMEISTER, A. R., STEVENS, C. W. AND YAKSH, T. L.: Interaction of intrathecal morphine and ST-91 on antinociception in the rat: dose-response analysis, antagonism and clearance. J. Pharmacol. Exp. Ther. 254: 383-392, 1990.
63. 2+ current in NG108-15 cells. J. Neurochem. 65: 1403-1406, 1995.
64. MUMBY, S. M. AND GILMAN, A. G.: Synthetic peptide antisera with determined specificity for G protein α or β subunits. Methods Enzymol. 195: 215-233, 1991.
65. MUTHAL, A. V. AND CHOPDE, C. T.: Modification of tricyclic antidepressant analgesia by calcium channel blockers. Indian J. Physiol. Pharmacol. 37: 238-240, 1993.
66. NESTLER, E. J. AND TALLMAN, J. F.: Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33: 127-132, 1988.
67. NICHOLSON, D., REID, A. AND SAWYNOK, J.: Effects of forskolin and phosphodiesterase inhibitors on spinal antinociception by morphine. Pharm. Biochem. Behav. 38: 753-758, 1991.
68. NORTH, R. A.: Opioid actions on membrane ion channels. Handbook Exp. Pharm. Opioids I 104/1: 773-797, 1993.
69. 3H-nitrendipine binding to synaptic membranes: similarity with morphine tolerance, Naunyn-Schniedeberg Arch. Pharmacol. 341: 123-127, 1990.
70. OMOTE, K., KITAHATA, L., COLLINS, J. G., NAKATANI, K. AND NAKAGAWA, I.: Interaction between opiate subtype and alpha-2 adrenergic agonists in suppression of noxiously evoked activity of WDR neurons in the spinal dorsal horn. Anesthesiology 74: 737-743, 1991.
71. OMOTE, K., SONODA, H., KAWAMATA, M., IWASAKI, H. AND NAMIKI, A.: Potentiation of antinociceptive effects of morphine by calcium-channel blockers at the level of the spinal cord. Anesthesiology 79: 746-752, 1993.
72. OSSIPOV, M. H., SUAREZ, L. J. AND SPAULDING, T. C.: Antinociceptive interactions between alpha-2-adrenergic and opiate agonists at the spinal level in rodents. Anesth. Analg. 68: 194-200, 1989.
73. PEREIRA, I. T., PRADO, W. A. PRADO AND REIS, M. P. D.: Enhancement of the epidural morphine-induced analgesia by systemic nifedipine. Pain 53: 341-355, 1993.
74. PEREZ-REYES, E. AND SCHNEIDER, T.: Calcium channels: structure, function and classification. Drug Dev. Res. 33: 295-318, 1994.
75. PIERCEY, M. F., MOON, M. W., BLINN, J. R. AND DOBRY-SCHREUR, P. J. K.: Analgesic activities of spinal cord substance P: Antagonists implicate substance P as a neurotransmitter of pain sensation. Brain Res. 385: 74-85, 1986.
76. PLUMMER, J. L., CMIELEWSKI, P. L., GOURLAY, G. K., OWEN, H. AND COUSINS, M. J.: Antinociceptive and motor effects of intrathecal morphine combined with intrathecal clonidine, noradrenaline, carbachol or midazolam in rats. Pain 49: 145-152, 1992.
77. PLUMMER, M. R., LOGOTHETIS, D. E. AND HESS, P.: Elementary properties and pharmacological sensitivities of calcium channels in mammalian peripheral neurons. Neuron 2: 1453-1463, 1989.
78. o protein messenger RNA levels in the rat hippocampus. Neuroscience 83: 1111-1116, 1994.
79. PRZEWLOCKI, R., COSTA, T., LANG, J. AND HERZ, A.: Pertussis toxin abolishes the antinociception mediated by opioid receptors in rat spinal cord, Eur. J. Pharmacol. 144: 91-95, 1987.
80. QUIJADA, L., GERMANY, A., HEENANDEZ, A. AND CONTREARAS, E.: Effects of calcium channel antagoniste and Bay K 8644 on the analgesic response to pentazocine and U50-488H. Gen. Pharmacol. 23: 837-842, 1992.
81. 3H] nitrendipine binding sites in the brain in morphine-tolerant mice. Eur. J. Pharmacol. 102: 371-372, 1984.
82. RAMKUMAR, V. AND EL-FAKAHANY, E. E.: Prolonged morphine treatment increases rat brain dihydropyridine binding sites: possible involvement in development of morphine dependence. Eur. J. Pharmacol. 146: 73-83, 1988.
83. RAVENS, U. AND SCHOPPER, H.-P.: Opposite cardiac actions of the enantiomers of Bay K 8644 at different membrane potentials in guinea-pig papillary muscles. Naunyn-Schmiedeberg Arch. Pharmacol. 341: 232-239, 1990.
84. RHIM, H. AND MILLER, R. J.: Opioid receptors modulate diverse types of calcium channels in the nucleus tractus solitarius of the rat. J. Neurosci. 14: 7608-7615, 1994.
85. ROERIG, S. C.: Decreased spinal morphine/clonidine antinociceptive synergism in morphine-tolerant mice. Life Sci. 56: PL.115-122, 1995.
86. ROERIG, S. C. AND FUJIMOTO, J. M.: Multiplicative interaction between intracerebroventricularly and intrathecally administered morphine for analgesia in mice: Involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 249: 762-768, 1989.
87. ROERIG, S. C., LOH, H. H. AND LAW, P. Y.: Requirement of ADP-ribosylation for the pertussis toxin-induced alteration in electrophoretic mobility of G-proteins. Biochem. Biophys. Res. Commun. 180: 1227-1232, 1991.
88. ROERIG, S. C., LOH, H. H. AND LAW, P. Y.: Identification of three separate guanine nucleotide-binding proteins that interact with the δ-opioid receptor in NG108-15 neuroblastoma x glioma hybrid cells. Mol. Pharmacol. 41: 822-831, 1992.
89. ROERIG, S. C., O'BRIEN, S. M., FUJIMOTO, J. M. AND WILCOX, G. L.: Tolerance to morphine analgesia: Decreased multiplicative interaction between spinal and supraspinal sites. Brain Res. 308: 360-363, 1984.
90. RUFFOLO, R. R., NICHOLS, A. J., STADEL, J. AND HIEBLE, J.P.: Structure and function of α-adrenoceptors, Pharmacol. Rev., 43, 475-505, 1991.
91. SANTILLAN, R., MAESTRE, J. M., HURLE, M. A. AND FLOREZ, J.: Enhancement of opiate analgesia by nimodipine in cancer patients chronically treated with morphine: A preliminary report. Pain 58: 129-132, 1994.
92. 2+ channel toxins: tools to study channel structure and function. Drug Dev. Res. 33: 319-343, 1994.
93. SHAH, S., DUTTAROY, A., DAVIS, T. AND YOBURN, B. C.: Spinal and supraspinal effects of pertussis toxin on opioid analgesia. Pharm. Biochem. Behav. 49: 773-776, 1994.
94. SMITH, F. L. AND STEVENS, D. L.: Calcium modulation of morphine analgesia: role of calcium channels and intracellular pool calcium. J. Pharmacol. Exp. Ther. 272: 290-299, 1995.
95. SPAMPINATO, S., SPERONI, E., GOVONI, P., PISTACCHIO, E., ROMAGNOLI, C., MUHARI, G. AND FERRI, S.: Effect of ω-conotoxin and verapamil on antinociceptive, behavioural and thermoregulatory responses to opioids in the rat Eur. J. Pharmacol. 254: 229-238, 1994.
96. SPAULDING, T. C., FIELDING, S., VANAFRO, J. J. AND LAL, H.: Antinociceptive activity of clonidine and its potentiation of morphine analgesia. Eur. J. Pharmacol. 58: 19-25, 1979.
97. SPIEGEL, A. M.: Antibodies as probes of the structure and function of heterotrimeric GTP-binding proteins, ADP-ribosylating toxins and G-proteins. American Soc. for Microbiology, Washington DC, pp. 207-224, 1990.
98. 123I]ω-conotoxin binding in mouse brain. Neurosci. Lett. 163: 193-196, 1993.
99. 2-Adrenoceptor modulation of nociception in rat spinal cord: Location, effects and interactions with morphine. Eur. J. Pharmacol. 138: 169-177, 1987.
100. SWEENEY, M. I., WHITE, T. D., JHANANDAS, K. H. AND SAWYNOK, J.: Morphine releases endogenous adenosine from the spinal cord in vivo. Eur. J. Pharmacol. 141: 169-170, 1987.
101. TALLARIDA, R. J. AND MURRAY, R. B.: Manual of Pharmacologic Calculations, Springer-Verlag, New York, 1987.
102. TALLARIDA, R. J., PORRECA, F. AND COWEN, A.: Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 45: 947-961, 1989.
103. TSIEN, R. W., LIPSCOMBE, D., MADISON, D. V., BLEY, K. R. AND FEX, A. P.: Multiple types of neuronal calcium channels and their selective modulation. Trends Neurosci. 11: 431-438, 1987.
104. VANVLIET, B. J., WARDEH, G., MULDER, A. H. AND SCHOFFELMEER, A. N. M.: Reciprocal effects of chronic morphine administration on stimulatory and inhibitory G-protein α-subunits in primary cultures of rat striatal neurons. Eur. J. Pharmacol. Mol. Pharmacol. Sec. 208: 341-342, 1991.
105. VAUPEL, D. B., LANGE, W. R. AND LONDON, E. D.: Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans. J. Pharmacol. Exp. Ther. 267: 1396-1394. 1993.
106. VOCCI, F. J., WELCH, S. P. AND DEWEY, W. L.: Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3;5′ cyclic monophosphate antinociception. J. Pharmacol. Exp. Ther. 214: 463-466, 1980.
107. WICKMAN, K. AND CLAPHAM, D. E.: Ion channel regulation by G proteins. Physiol. Rev. 75: 865-885, 1995.
108. WILCOX, G. L., CARLSSON, K.-H., JOCHIM, A. AND JURNA, I.: Mutual potentiation of antinociceptive effects of morphine and clonidine on motor and sensory responses in rat spinal cord. Brain Res. 405: 84-93, 1987.
109. 2+ channel and the cation sensitivity of ω-conotoxin GVIA binding. Neuropharmacology 32: 1127-1139, 1993.
110. WONG, C. S., SU, Y. F., WATKINS, W. D. AND CHANG, K. J.: Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J. Pharmacol. Exp. Ther. 262: 317-326, 1992.
111. YAKSH, T. L.: Direct evidence that spinal serotonin and noradrenaline terminais mediate the spinal antinociceptive effects of morphine in the periaque-ductal gray. Brain Res. 160: 180-185, 1979.
112. YAKSH, T. L., JESSELL, T. M., GAMSE, R., MUDGE, A. W. AND LEEMAN, S. E.: Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 286: 155-157, 1980.
113. YAKSH, T. L. AND REDDY, S. V. R.: Studies in the primate on the analgetic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anesthesiology 54: 451-467, 1981.
114. YAKSH, T. L. AND RUDY, T. A.: Analgesia mediated by a direct spinal action of narcotics. Science 192: 1357-1358, 1976.
115. YEUNG, J. C. AND RUDY, T. A.: Sites of antinociceptive action of systemically injected morphine: Involvement of supraspinal loci as revealed by intracerebroventricular injection of naloxone, J. Pharmacol. Exp. Ther. 215: 626-632, 1980a.
116. YEUNG, J. C. AND RUDY, T. A.: Multiplicative interaction between narcotic agonisms expressed at spinal and supraspinal sites of antinociceptive action as revealed by concurrent intrathecal and intracerebroventricular injections of morphine. J. Pharmacol. Exp. Ther. 215: 633-642, 1980b.